News
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) reported second-quarter financial results and provided a detailed business update, emphasizing progress toward a 2027 Biologics License ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback